Avicanna Inc (AVCN) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.075x

Based on the latest financial reports, Avicanna Inc (AVCN) has a cash flow conversion efficiency ratio of -0.075x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-956.36K ≈ $-691.82K USD) by net assets (CA$12.79 Million ≈ $9.25 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See AVCN equity to assets ratio to measure how much of total assets are equity-financed.

Avicanna Inc - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Avicanna Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check AVCN cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Avicanna Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Avicanna Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
LX Hausys Ltd Preferred KO:108675	0.096x
Spire Healthcare Group Plc LSE:SPI	0.151x
Ata Gayrimenkul Yatirim Ortakligi AS IS:ATAGY	0.003x
Daewoo SBI SPAC 1 KQ:215480	-0.037x
Wooree Lighting Co.Ltd KQ:037400	-0.060x
Activeport Group Ltd AU:ATV	-0.155x
Daedong Metals Co. Ltd KQ:020400	-0.060x
Armlogi Holding Corp. Common Stock NASDAQ:BTOC	-0.157x

Annual Cash Flow Conversion Efficiency for Avicanna Inc (2016–2025)

The table below shows the annual cash flow conversion efficiency of Avicanna Inc from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Avicanna Inc.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CA$11.39 Million ≈ $8.24 Million	CA$-1.18 Million ≈ $-854.49K	-0.104x	+60.32%
2024-12-31	CA$9.74 Million ≈ $7.05 Million	CA$-2.55 Million ≈ $-1.84 Million	-0.261x	-48.44%
2023-12-31	CA$7.97 Million ≈ $5.77 Million	CA$-1.40 Million ≈ $-1.02 Million	-0.176x	+91.81%
2022-12-31	CA$3.46 Million ≈ $2.50 Million	CA$-7.44 Million ≈ $-5.38 Million	-2.150x	-27.33%
2021-12-31	CA$6.91 Million ≈ $5.00 Million	CA$-11.66 Million ≈ $-8.44 Million	-1.688x	-68.10%
2020-12-31	CA$13.91 Million ≈ $10.06 Million	CA$-13.97 Million ≈ $-10.11 Million	-1.004x	-54.28%
2019-12-31	CA$29.88 Million ≈ $21.61 Million	CA$-19.45 Million ≈ $-14.07 Million	-0.651x	-244.11%
2018-12-31	CA$26.38 Million ≈ $19.08 Million	CA$-4.99 Million ≈ $-3.61 Million	-0.189x	+92.54%
2017-12-31	CA$841.07K ≈ $608.42K	CA$-2.13 Million ≈ $-1.54 Million	-2.537x	-506.93%
2016-12-31	CA$-29.76K ≈ $-21.53K	CA$-18.55K ≈ $-13.42K	0.623x	--

About Avicanna Inc

TO:AVCN Canada Drug Manufacturers - Specialty & Generic

Market Cap

$11.37 Million

CA$15.72 Million CAD

Market Cap Rank

#26699 Global

#1088 in Canada

Share Price

CA$0.13

Change (1 day)

+0.00%

52-Week Range

CA$0.11 - CA$0.30

All Time High

CA$6.90